NEXLIZET (bempedoic acid and ezetimibe) tablets, 180 mg/10 mg, 30-count bottle, Rx only, Manufactured for: Esperion Therapeutics, Ann Arbor, MI 48108, NDC 72426-818-03
Reason
Failed dissolution specifications: out-of-specification bempedoic acid dissolution at the 0-month timepoint.
Classification
Class III
Status
Completed
Lot
Lot #, 1990305, Exp 08-31-2025
Date
Disclaimer: This tool indexes published US FDA drug-enforcement recall records from all countries, limited to the latest five years. A company or product not appearing here is not proof that it is compliant, approved, safe, or free of FDA action.